APC148   Click here for help

GtoPdb Ligand ID: 13418

Synonyms: ZN148
Compound class: Synthetic organic
Comment: APC148 (ZN148) is a zinc-chelating β-lactamase inhibitor [1]. It is in clinical development as an adjuvant to be used with reserve group antibacterials for the treatment of patients with complicated Gram-negative infections.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 11
Hydrogen bond donors 5
Rotatable bonds 14
Topological polar surface area 161.78
Molecular weight 511.57
XLogP -4.69
No. Lipinski's rules broken 3

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CN(C[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O)C(=O)C1=CC=C(CN(CC2=NC=CC=C2)CC3=NC=CC=C3)N=C1
Isomeric SMILES CN(C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO)C(=O)C1=CC=C(CN(CC2=NC=CC=C2)CC3=NC=CC=C3)N=C1
InChI InChI=1S/C26H33N5O6/c1-30(16-22(33)24(35)25(36)23(34)17-32)26(37)18-8-9-21(29-12-18)15-31(13-19-6-2-4-10-27-19)14-20-7-3-5-11-28-20/h2-12,22-25,32-36H,13-17H2,1H3/t22-,23+,24+,25+/m0/s1
InChI Key YDMPBIVRJWWDAB-ZYQDXHPFSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

No information available.
Summary of Clinical Use Click here for help
A Phase 1 first-in-human trial to evaluate the safety, tolerability, and pharmacokinetics of APC148 in healthy adults (NCT06360640) has been registered but is not yet recruiting (last update April 2024).
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT06360640 A First-in-human Trial to Evaluate Safety, Tolerability, and Pharmacokinetics of APC148 in Healthy Adults Phase 1 Interventional AdjuTec Pharma AS